Duvelisib 25 MG Oral Capsule — RxCUI 2058523
RxNorm drug concept · Semantic clinical drug
RxCUI 2058523
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2058523
Official nameDuvelisib 25 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Duvelisib: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats adults with CLL, SLL or follicular lymphoma that has come back or stopped responding after at least two earlier treatments. It is not recommended as a first- or second-li...
- Swallow the capsule whole twice a day, with or without food. Don't open, break or chew it. If you're less than 6 hours late on a dose, take it right away. If it's more than 6 hours...
- Diarrhea, low white blood cells, rash, tiredness, fever, cough and nausea are common. Call us or your doctor if you have diarrhea that is new or worsening, a rash, a fever or infec...
- Duvelisib raises infection risk, so your doctor will give you preventive medicine for Pneumocystis pneumonia and may consider antivirals for CMV. You'll also have regular blood and...
🕸️ Concept Web — How Duvelisib 25 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Duvelisib 25 MG Oral Capsule
RxCUI 2058523 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Duvelisib
2058509IN
-
Duvelisib
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Copiktra
2058515BN
-
Copiktra
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Duvelisib Oral Capsule
2058513SCDF -
Duvelisib Oral Product
2058511SCDG -
Duvelisib Pill
2058512SCDG -
Duvelisib Oral Capsule [Copiktra]
2058517SBDF -
Copiktra Oral Product
2058518SBDG -
Copiktra Pill
2058519SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Duvelisib Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Duvelisib 25 MG
2058522SCDC -
Duvelisib 25 MG Oral Capsule [Copiktra]
2058525SBD -
Duvelisib 25 MG [Copiktra]
2058524SBDC
-
Duvelisib 25 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Duvelisib 25 MG
SCDC · 2058522 -
Duvelisib Oral Capsule
SCDF · 2058513 -
Duvelisib Oral Product
SCDG · 2058511 -
Duvelisib Pill
SCDG · 2058512
Brand-Name Concepts
-
Duvelisib 25 MG Oral Capsule [Copiktra]
SBD · 2058525 -
Duvelisib 25 MG [Copiktra]
SBDC · 2058524 -
Duvelisib Oral Capsule [Copiktra]
SBDF · 2058517 -
Copiktra Oral Product
SBDG · 2058518 -
Copiktra Pill
SBDG · 2058519 -
Copiktra
BN · 2058515
📦 FDA Products & Package NDCs
2 products · 4 package NDCs
4 package NDCs map to RxCUI 2058523 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 73116-0215-28 | 28 CAPSULE in 1 PACKAGE (73116-215-28) | COPIKTRA | Secura Bio, Inc | 2018-09-25 |
| 73116-0215-56 | 56 CAPSULE in 1 PACKAGE (73116-215-56) | COPIKTRA | Secura Bio, Inc | 2018-09-25 |
| 73116-0225-28 | 28 CAPSULE in 1 PACKAGE (73116-225-28) | COPIKTRA | Secura Bio, Inc | 2018-09-25 |
| 73116-0225-56 | 56 CAPSULE in 1 PACKAGE (73116-225-56) | COPIKTRA | Secura Bio, Inc | 2018-09-28 |
Observed labelers:
Secura Bio, Inc (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.